rs111759069

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_019066.5(MAGEL2):​c.1079C>T​(p.Ala360Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0098 in 1,504,542 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A360A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0069 ( 7 hom., cov: 33)
Exomes 𝑓: 0.010 ( 107 hom. )

Consequence

MAGEL2
NM_019066.5 missense

Scores

2
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.469

Publications

3 publications found
Variant links:
Genes affected
MAGEL2 (HGNC:6814): (MAGE family member L2) Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. [provided by RefSeq, Oct 2010]
MAGEL2 Gene-Disease associations (from GenCC):
  • Schaaf-Yang syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0054139197).
BP6
Variant 15-23646664-G-A is Benign according to our data. Variant chr15-23646664-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 193398.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00691 (1052/152188) while in subpopulation NFE AF = 0.0125 (850/67982). AF 95% confidence interval is 0.0118. There are 7 homozygotes in GnomAd4. There are 453 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1052 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGEL2NM_019066.5 linkc.1079C>T p.Ala360Val missense_variant Exon 1 of 1 ENST00000650528.1 NP_061939.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGEL2ENST00000650528.1 linkc.1079C>T p.Ala360Val missense_variant Exon 1 of 1 NM_019066.5 ENSP00000497810.1

Frequencies

GnomAD3 genomes
AF:
0.00692
AC:
1053
AN:
152070
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00249
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00424
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0125
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00570
AC:
642
AN:
112578
AF XY:
0.00581
show subpopulations
Gnomad AFR exome
AF:
0.00124
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.000176
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00467
Gnomad NFE exome
AF:
0.0126
Gnomad OTH exome
AF:
0.00496
GnomAD4 exome
AF:
0.0101
AC:
13691
AN:
1352354
Hom.:
107
Cov.:
32
AF XY:
0.00986
AC XY:
6540
AN XY:
663390
show subpopulations
African (AFR)
AF:
0.00181
AC:
56
AN:
30892
American (AMR)
AF:
0.00152
AC:
50
AN:
32998
Ashkenazi Jewish (ASJ)
AF:
0.000220
AC:
5
AN:
22694
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35458
South Asian (SAS)
AF:
0.000355
AC:
26
AN:
73342
European-Finnish (FIN)
AF:
0.00446
AC:
145
AN:
32508
Middle Eastern (MID)
AF:
0.000728
AC:
4
AN:
5492
European-Non Finnish (NFE)
AF:
0.0123
AC:
13033
AN:
1062498
Other (OTH)
AF:
0.00659
AC:
372
AN:
56472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
905
1809
2714
3618
4523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00691
AC:
1052
AN:
152188
Hom.:
7
Cov.:
33
AF XY:
0.00609
AC XY:
453
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00248
AC:
103
AN:
41532
American (AMR)
AF:
0.00189
AC:
29
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5132
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00424
AC:
45
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0125
AC:
850
AN:
67982
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
54
108
162
216
270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00484
Hom.:
2
Bravo
AF:
0.00663
TwinsUK
AF:
0.0113
AC:
42
ALSPAC
AF:
0.0130
AC:
50
ExAC
AF:
0.00128
AC:
31
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MAGEL2: BS1, BS2 -

May 19, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Jul 29, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 13, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
17
DANN
Benign
0.82
DEOGEN2
Benign
0.038
T;T
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.48
.;T
MetaRNN
Benign
0.0054
T;T
PhyloP100
0.47
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.1
N;.
Sift
Uncertain
0.019
D;.
Sift4G
Benign
0.32
T;.
Vest4
0.12
MVP
0.14
GERP RS
2.1
Varity_R
0.030
gMVP
0.058

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111759069; hg19: chr15-23891811; API